Literature DB >> 22845310

Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.

Amer Zeidan, Javier Bolaños-Meade, Yvette Kasamon, Joseph Aoki, Michael Borowitz, Lode Swinnen, Heather Symons, Leo Luznik, Ephraim Fuchs, Richard Jones, Richard Ambinder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22845310      PMCID： PMC4234092          DOI： 10.3109/10428194.2012.717082

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  14 in total

1.  A case of hemolytic anemia and severe thrombocytopenia related to histiocytic sarcoma.

Authors:  Sandip Patel; Jonathan Said; Sophie Song; Wade Nishimoto; Ronald Paquette
Journal:  Leuk Res       Date:  2010-05-15       Impact factor: 3.156

2.  [Allogeneic bone marrow transplantation for a patient with malignant histiocytosis].

Authors:  M Zhai; L Hu; H Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1997-08

3.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Authors:  Claudio G Brunstein; Ephraim J Fuchs; Shelly L Carter; Chatchada Karanes; Luciano J Costa; Juan Wu; Steven M Devine; John R Wingard; Omar S Aljitawi; Corey S Cutler; Madan H Jagasia; Karen K Ballen; Mary Eapen; Paul V O'Donnell
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

4.  Bone marrow transplantation for malignant histiocytosis.

Authors:  M R Vowels; L White; P R Lam-Po-Tang
Journal:  Bone Marrow Transplant       Date:  1987-06       Impact factor: 5.483

5.  Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant.

Authors:  J Berry; J A Russell
Journal:  Bone Marrow Transplant       Date:  1989-01       Impact factor: 5.483

6.  Successful autologous bone marrow transplantation in second remission of malignant histiocytosis.

Authors:  B Cazin; N C Gorin; J P Jouet; J P Laporte; P Fenaux; M P Walter; A Najman; B Gosselin; F Bauters
Journal:  Bone Marrow Transplant       Date:  1990-06       Impact factor: 5.483

7.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

8.  Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.

Authors:  Jason L Hornick; Elaine S Jaffe; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

9.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Authors:  Muneer H Abidi; Isaacson Tove; Rami B Ibrahim; Dan Maria; Edward Peres
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

10.  Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.

Authors:  J Bolaños-Meade; L Luznik; M Muth; W H Matsui; C A Huff; B D Smith; M Y Levy; Y L Kasamon; L J Swinnen; J D Powell; R A Brodsky; R F Ambinder; R J Jones; E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2008-11-03       Impact factor: 5.483
View more
  3 in total

1.  Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.

Authors:  Hideki Tsujimura; Toshiko Miyaki; Shuhei Yamada; Takeaki Sugawara; Mikiko Ise; Shintaro Iwata; Tsukasa Yonemoto; Dai Ikebe; Makiko Itami; Kyoya Kumagai
Journal:  Int J Hematol       Date:  2014-07-26       Impact factor: 2.490

2.  Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.

Authors:  Sophie Voruz; Anne Cairoli; Olaia Naveiras; Laurence de Leval; Edoardo Missiaglia; Krisztian Homicsko; Olivier Michielin; Sabine Blum
Journal:  Haematologica       Date:  2017-11-02       Impact factor: 9.941

3.  Successful Treatment of Multifocal Histiocytic Sarcoma Occurring after Renal Transplantation with Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) Followed by Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Julia Tomlin; Ryan K Orosco; Sarah Boles; Ann Tipps; Huan-You Wang; Jacob Husseman; Matthew Wieduwilt
Journal:  Case Rep Hematol       Date:  2015-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.